Thursday, July 10, 2008

A New Rotavirus Vaccine: RotaShield®

arava

A New Rotavirus Vaccine: RotaShield®


from Pediatric Pharmacotherapy

Summary


The rotavirus vaccine offers the benefit of reducing the severity of rotaviral gastrointeritis in infants, with the potential to reduce the need for hospitalization and intravenous rehydration in severely affected patients. In addition, it may reduce the need for physician office visits and parental time lost from work. The true value of the vaccine, however, remains to be proven. While the adoption of this vaacine into the routine childhood immunization schedule in the United States appears likely, its benefits must be weighed against the high cost of the available product.



This is a part of article A New Rotavirus Vaccine: RotaShield® Taken from "Arava Information" Information Blog

No comments: